Acquisitions

Will create networking industry powerhouse with a proven, edge-to-data center set of solutions and global reach

PALO ALTO, Calif., and MARLBOROUGH, Mass., Nov. 11, 2009 -- HP and 3Com Corporation (NASDAQ: COMS) (“3Com”) today announced that they have entered into a definitive agreement under which HP will purchase 3Com, a leading provider of networking switching, routing and security solutions, at a price of $7.90 per share in cash or an enterprise value of approximately $2.7 billion. The terms of the transaction have been approved by the HP and 3Com boards of directors.    » read more »

November 2, 2009 -- Abbott Park, Illinois (NYSE: ABT) — Abbott announced today that it has completed its acquisition of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of mitral valves.

The acquisition provides Abbott with a leading presence in the growing area of non-surgical treatment for structural heart disease.Evalve's minimally invasive catheter-based MitraClip® system is the first commercially available treatment option approved in Europe for non-surgical mitral valve repair for patients suffering from the effects of mitral regurgitation – a condition that prevents the heart's mitral valve from closing completely The MitraClip system is an investigational device in the United States and is currently in clinical trials.    » read more »

Addition of Fort Dodge Animal Health Products Diversifies and Enhances Pfizer’s Already Robust U.S. Portfolio

October 19, 2009 -- NEW YORK -- A new Pfizer Animal Health was unveiled last week as Pfizer's acquisition of Wyeth, including its subsidiary Fort Dodge Animal Health, was completed. Pfizer Animal Health is now the world’s leader in the discovery, development, manufacture and sales of veterinary vaccines and medicines for livestock and companion animals.    » read more »

Dallas, Texas, Wall, New Jersey, September 14, 2009 -- AT&T* and Centennial Communications Corp. (NASDAQ: CYCL) announced today that, assuming timely satisfaction or waiver of all remaining closing conditions including receipt of the required regulatory approvals, they now anticipate the pending acquisition of Centennial by AT&T to be completed early in the fourth quarter of calendar year 2009. On November 7, 2008, the two companies entered into an agreement under which AT&T would acquire Centennial. Under the terms of the merger agreement, Centennial stockholders would receive $8.50 per share in cash.    » read more »

Company cites additional upside value identified since initial offer; also shares details on financing

CHICAGO (July 2, 2009) -- Exelon Corporation (NYSE:EXC) today announced an increase in its offer to acquire all of the outstanding NRG common stock in an all-stock transaction with a fixed exchange ratio of 0.545 of a share of Exelon common stock for each NRG share, a 12.4 percent increase over the initial exchange offer of 0.485. Exelon’s increased offer represents value of over $3 billion to NRG shareholders.    » read more »

U.S. District Court Upholds Exelon’s Exchange Offer to Acquire NRG; Court ruling that NRG allegations are without merit considered a major step in proposed acquisition

CHICAGO (June 22, 2009) – The U.S. District Court for the Southern District of New York today ruled that the remaining allegations raised in a suit filed by NRG Energy, Inc. (NYSE:NRG) on March 17 are without merit.

The court had earlier dismissed other allegations in NRG’s lawsuit. By order dated June 19, the judge rejected NRG’s remaining claim that Exelon Corporation (NYSE:EXC) does not intend to complete the exchange offer according to its terms and entered judgment in favor of Exelon.    » read more »

ST. LOUIS, June 22, 2009 – The Boeing Company [NYSE: BA] has completed its acquisition of eXMeritus Inc., a Fairfax, Va.-based company that provides hardware and software to federal government and law enforcement organizations for sharing information securely across classified and unclassified networks and systems.

eXMeritus will operate within Boeing Integrated Defense Systems' Network and Space Systems unit. The acquisition, announced on June 15, 2009, is part of Boeing's strategy to expand its presence in the cyber and intelligence markets. Terms of the transaction are not being disclosed.    » read more »

ST. LOUIS, June 15 -- The Boeing Company (NYSE: BA) today announced it has signed an agreement to acquire eXMeritus, Inc., a Fairfax, Va.-based company that provides hardware and software to federal government and law enforcement organizations for sharing information securely across classified and unclassified networks and systems.

eXMeritus' products are certified and accredited by the U.S. government to perform this function on its most trusted systems. The decision to buy eXMeritus complements last year's acquisitions of Digital Receiver Technology, Ravenwing and Kestrel Enterprises. These acquisitions are key moves in the company's strategy to expand its presence in the cyber and intelligence markets.    » read more »

New Brunswick, NJ (June 5, 2009) -- Johnson & Johnson (NYSE: JNJ), through a new wholly-owned subsidiary, Kite Merger Sub, Inc., today will commence a cash tender offer to purchase all outstanding shares of common stock of Cougar Biotechnology, Inc. (Nasdaq: CGRB). Johnson & Johnson reported on May 21, 2009, its intent to acquire Cougar Biotechnology.    » read more »

Vancouver, BC -- June 1, 2009 -- GE Energy Financial Services announced today it has signed an agreement with EarthFirst Canada Inc. (TSX: EF, EF.WT) to consider purchasing the up to 300-megawatt Dokie Ridge Wind Project, the largest wind farm project under construction in British Columbia. Subject to satisfaction of conditions, including due diligence and internal approvals, GE Energy Financial Services has agreed to form a partnership with Plutonic Power Corporation (TSX: PCC) which, provided the acquisition is completed, will own and operate the project, located 1,100 kilometres northeast of Vancouver, near Chetwynd.    » read more »

Industrial Machinery Company To Invest in Growth and Global Expansion of Premium Off-Road Vehicle Brand; Deal is Expected to Secure Over 3,000 US Jobs

DETROIT and SICHUAN, June 2, 2009 - Sichuan Tengzhong Heavy Industrial Machinery Co., Ltd (Tengzhong) and General Motors Corp. today confirmed details of their proposed transaction, pursuant to which, Tengzhong, a major industrial machinery group, will acquire the rights to the premium off-road HUMMER brand, along with a senior management and operational team.    » read more »

San Francisco — May 29, 2009 -- Sstatement from Wells Fargo & Company (NYSE: WFC) regarding Emerisque’s offer for Hartmarx Corp.:

The group of banks led by Wells Fargo as agent, which has provided credit to Hartmarx Corp., said today it opposes Emerisque’s offer to acquire Hartmarx, which has been in Chapter 11 since January 2009 and has been unable to repay more than $114 million that it owes the bank group.    » read more »

Definitive agreement to acquire EBEWE Pharma's specialty injectables business for EUR 925 million (USD 1.2 billion) in an all-cash transaction

May 20, 2009 -- Basel, May 20, 2009 - Novartis has signed a definitive agreement to acquire the specialty generic injectables business of EBEWE Pharma, providing Sandoz - the Group's generic pharmaceuticals division - an opportunity to create a strong global platform for future growth while improving access for patients worldwide to many generic oncology medicines.

Under terms of the agreement, Novartis will acquire this business for EUR 925 million (USD 1.2 billion) in cash. Excluded from this transaction is EBEWE Pharma's separate injectable neurological products business.    » read more »

Access to Late-Stage, First-in-Class Prostate Cancer Treatment Strengthens Presence in Oncology

New Brunswick, NJ, and Los Angeles, CA. (May 21, 2009) – Johnson & Johnson (NYSE: JNJ) and Cougar Biotechnology, Inc. (NASDAQ: CGRB), a development stage biopharmaceutical company with a specific focus on oncology, today announced a definitive agreement whereby Cougar Biotechnology will be acquired for approximately $1.0 billion in a cash tender offer.

Cougar Biotechnology, which has compounds in development for the treatment of prostate cancer, as well as breast cancer and multiple myeloma, will work with Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., a Johnson & Johnson company.    » read more »

Commission’s unanimous approval considered a major step in completing the regulatory approval process

CHICAGO (May 21, 2009) – The Federal Energy Regulatory Commission (FERC) today unanimously approved Exelon Corporation’s (NYSE: EXC) application for its proposed acquisition of NRG Energy, Inc. (NYSE: NRG), as required by Section 203 of the Federal Power Act, a significant step toward completion of the regulatory approval process.    » read more »